The squamous non-small cell lung cancer market is projected to grow at a CAGR of 10.8% till 2030 Advances in molecular biology and tumor immunology have enabled the development of NSCLC targeting therapies, which have the ability to impede cancer growth by altering chemical reactions associated with oncogenic driver mutations For additional details, please visit https://www.rootsanalysis.com/reports/squamous-non-small-cell-lung-cancer-market.html